Search- Innovative early clinical development strategies
- Focus on innovative cell and gene therapies and rare diseases
- Development of master protocols and adaptive trials to strengthen study design and ease patient burden
With CNS therapies - time is of the essence
Simplifying trial complexities to navigate you forward
Developing successful central nervous system (CNS) drugs is a complex process. From conducting lengthy studies and finding hyperspecialized sites to completing patient recruitment and meeting strict regulatory guidelines — the challenges can seem endless. And for patients who urgently need these therapeutics, time is of the essence. That’s why you need a CNS CRO partner who understands the complexities at every step and across a wide range of indications.
Our dedicated teams have extensive experience to ensure your clinical trial is completed on time and on budget. Coupled with unparalleled data and insights, our flexible delivery model gives you the confidence you need to bring innovative CNS therapies to patients who need it most.
Patient centricity is key in study design and operationalization. At IQVIA Biotech we design the study to support the specific needs of CNS patient populations because we are driven to make a positive difference in their lives.
Our goal is to improve the quality of life of patients with neurological diseases through advances in clinical research. Our experts walk our biotech clients through every step of the process, ensuring they know what to expect when carrying out neurology trials and how to successfully reach trial endpoints with efficient trial design and risk mitigation.
Leading neuroscience expertise
Clinical research in neurological disorders is making great advances in bringing new therapies to patients with unmet medical needs. However, indications such as Alzheimer’s disease and neuro-orphan diseases lack effective therapies.
IQVIA Biotech delivers full-service clinical trial solutions — from early asset strategy and clinical development planning all the way to approval. Leverage our scientific experts, data and global resources so you can focus on what matters most: getting breakthrough treatments to patients.
Our CNS team is here to support your clinical trial
- More than 1,000 CNS clinical trials in the past 10 years
- Board-certified neurologists on staff
- Experts in neuroscience clinical research, specifically in neurology, psychiatry, neuropathic pain and rare diseases
- Global CNS key opinion leaders and site networks
- Regional regulatory expertise
NEUROSCIENCE INSIGHTS
SOLUTION
IQVIA CNS COE
Delivering novel CNS therapies is scientifically, medically and operationally complex. At IQVIA, we have more data and insights than ever before to drive innovation forward.
OPERATIONAL EXCELLENCE
INNOVATIVE SOLUTIONS
- Decentralized and hybrid trial solutions to take trials directly to the patient
- Global site capabilities to identify site capacity requirements to meet trial endpoints
DATA-DRIVEN MODELS
- Data-driven models to increase diversity and reliability of patient populations
- Device and wearables capabilities to improve objectivity of outcome measurements
Discover new opportunities with Connected Intelligence
Drawing on IQVIA's unparalleled data, analytics and technologies, IQVIA Biotech brings together experience in neuroscience clinical research, data-driven capabilities, and flexible clinical solutions to help customers accelerate clinical development of innovative CNS treatments.
Connected Intelligence enables our team to manage trial complexity and increase predictability and speed.
Obesity Center of Excellence
Accelerate your obesity trial timelines with solutions designed for rapid execution.
Related Solutions
Real World Evidence
Generate and disseminate the right real world evidence (RWE) to meet stakeholder needs with confidence.
Rare Disease Expertise
Build on our experience of more than 300 rare disease studies to fulfill your promise of hope to millions around the world.
Integrated Commercial Solutions
Connect data, analytics, domain expertise, and technology to uncover actionable insights and maximize commercial effectiveness.